Showing results (141-150 of 238) with videos related to
Sort By:
Pageof 24
Cancer Chemotherapy and Pharmacology|May 25, 2007
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesotheliomaGavin J Gordon, Madhubalan Mani, Gautam Maulik, et al.AJR. American Journal of Roentgenology|July 24, 2010
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypesRitu R Gill, Shigeaki Umeoka, Hatsuho Mamata, et al.Journal of Magnetic Resonance Imaging : JMRI|March 31, 2011
Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imagingJunichi Tokuda, Hatsuho Mamata, Ritu R Gill, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Human liver dendritic cells promote T cell hyporesponsivenessZubin M Bamboat, Jennifer A Stableford, George Plitas, et al.Bioinformatics (Oxford, England)|September 14, 2010
Semi-supervised recursively partitioned mixture models for identifying cancer subtypesDevin C Koestler, Carmen J Marsit, Brock C Christensen, et al.The Annals of Thoracic Surgery|December 12, 2003
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancerKimberly A Moore, Carlos M Mery, Michael T Jaklitsch, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 12, 2011
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomyDavid J Sugarbaker, Andrea S Wolf, Lucian R Chirieac, et al.The Journal of Thoracic and Cardiovascular Surgery|February 26, 2013
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resectionDavid J Sugarbaker, Ritu R Gill, Beow Y Yeap, et al.Med (New York, N.Y.)|May 28, 2026
Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivityMiguel A Lopez-Lago, Meriem Taleb, Mehek Ningoo, et al.Cancer|August 8, 2019
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesotheliomaLucian R Chirieac, Yin P Hung, Wai Chin Foo, et al.Pageof 24